|
MechanismMAGEA1 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Beijing Kerui Biological Technology Co., Ltd.
0 Patents (Medical) associated with Beijing Kerui Biological Technology Co., Ltd.
100 Deals associated with Beijing Kerui Biological Technology Co., Ltd.
100 Translational Medicine associated with Beijing Kerui Biological Technology Co., Ltd.